Evidence map›Paper›PMID 42472753›Full record

ArticleAnnals of surgical oncology2026

Preoperative Radiologic Assessment of the Axilla in Locally Advanced Breast Cancer After Neoadjuvant Systemic Therapy: A Contemporary Comparison.

Andrew Seto, Elisa Port, Stephanie Bernik, Tianxiang Sheng, Tara Balija

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrew SetoIcahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA. andrew.seto.md@gmail.com.ORCID http://orcid.org/0000-0003-4248-3082
Elisa PortIcahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA.
Stephanie BernikIcahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA.
Tianxiang ShengIcahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA.
Tara BalijaIcahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA.ORCID https://orcid.org/0000-0002-6236-6089

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrior studies comparing different imaging modalities in assessing axillary response after neoadjuvant systemic therapy (NST) in locally advanced breast cancer (LABC) are limited. This study evaluated the efficacy of different imaging modalities in identifying residual lymphadenopathy after NST in modern cohort of LABC patients.

methodsA retrospective review was performed examining LABC patients undergoing NST followed by surgical axillary staging from 2018 to 2023. Patients with LABC (T3-4,N1-3 or any T stage with N2-3 disease) were included. Inflammatory breast cancer was excluded. The efficacy of US, MRI, and PET/CT in evaluating residual nodal disease and the variables associated with radiologic-pathologic concordance were analyzed.

resultsA total of 101 patients meeting inclusion were identified. Post-NST imaging included US (n = 57), MRI (n = 53), and PET/CT (n = 45). Ultrasound had the highest sensitivity of 71% and positive predictive value of 76%. PET/CT had the highest specificity of 73% and negative predictive value of 70%. MRI had the lowest performance in all diagnostic measures. There was a significant relationship between complete imaging response (CIR)-pathologic complete response (pCR) concordance and pretreatment nodal status (χ

conclusionsPost-NST imaging provides valuable information on treatment response in LABC. However, CIR should not preclude surgical axillary evaluation. Further studies investigating the relationships between pre-treatment nodal status in LABC patients and radiologic-pathologic complete response after NST are warranted.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsLymph NodesNeoadjuvant TherapyAgedAxillaFemaleFollow-Up StudiesHumansLymphatic MetastasisMagnetic Resonance ImagingMiddle AgedPathologic Complete ResponsePositron Emission Tomography Computed TomographyPreoperative CarePrognosisAxillary stagingImagingLocally advanced breast cancerLymph nodeNeoadjuvant therapyResidual lymphadenopathy

Identifiers

PMID42472753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.